NCT01422941
Completed
Phase 1
A PROSPECTIVE, MULTI-CENTER CLINICAL EVALUATION TO ASSESS SAFETY AND PERFORMANCE OF CAVU MEDICAL, INC.'S ATTUNE TUBING WHEN USED WITH NEWLY-IMPLANTED LAPAROSCOPIC ADJUSTABLE GASTRIC BANDS (LAGBs)
Cavu Medical, Inc.2 sites in 1 country40 target enrollmentOctober 2010
ConditionsObesity
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- Obesity
- Sponsor
- Cavu Medical, Inc.
- Enrollment
- 40
- Locations
- 2
- Primary Endpoint
- The rate of successful placement and filling of the CAVU Medical Attune device without serious device-related adverse events.
- Status
- Completed
- Last Updated
- 10 years ago
Overview
Brief Summary
The objectives of this clinical research project are to demonstrate the safety and feasibility of CAVU Medical, Inc.'s Attune Device.
Investigators
Eligibility Criteria
Inclusion Criteria
- •The subject is at least 18 years of age.
- •The subject has been informed of the nature of the trial and agrees to its provisions.
- •The subject has a pre-implantation BMI within the protocol limits.
- •The subject agrees to the follow-up visit schedule.
- •The subject is a candidate for a LAGB procedure.
- •The subject agrees to comply with specified follow-up evaluations.
- •The subject is willing to fast for 2 hours prior to each adjustment visit.
Exclusion Criteria
- •The subject is pregnant or is not willing to use an effective method of birth control for the duration of the trial.
- •The subject has a condition that is contraindicated for LAGB procedures.
- •The subject is currently using weight loss medications or supplements.
- •The subject has a concurrent terminal medical condition with a life expectancy of less than 12 months.
- •The subject is currently participating in an investigational drug or another medical device trial.
- •The subject had a previous LAGB procedure.
- •The Investigator believes that the patient has physical or mental conditions that would render trial participation inappropriate.
Outcomes
Primary Outcomes
The rate of successful placement and filling of the CAVU Medical Attune device without serious device-related adverse events.
Time Frame: 30 Days
Study Sites (2)
Loading locations...
Similar Trials
Completed
Not Applicable
Safety and Performance Evaluation of the Calcivis SystemDental CariesNCT02780856Calcivis Ltd110
Completed
Phase 3
Safety and Effectiveness Study of the TOPS System, a Total Posterior Arthroplasty Implant Designed to Alleviate Pain Resulting From Moderate to Severe Lumbar StenosisLow Back PainLeg PainSpondylolisthesisLumbar Spinal StenosisNCT00405691Impliant, Ltd.450
Completed
Not Applicable
CellFX Treat & Resect Low-Risk BCC Feasibility StudyBCC - Basal Cell CarcinomaBCCExcision MarginNCT04918381Pulse Biosciences, Inc.30
Completed
Not Applicable
Treatment for Stress and Mixed Urinary Incontinence and Vaginal Vault ProlapseUrinary Incontinence, StressMixed IncontinenceVaginal Vault ProlapseNCT00223106Medtronic - MITG467
Recruiting
Not Applicable
Coronary Crossing System in Patients With Coronary Chronic Total OcclusionsChronic Total Occlusion of Coronary ArteryNCT05813704Shanghai MicroPort Rhythm MedTech Co., Ltd.156